Transition Therapeutics Inc. announced that the first patient has been dosed in a Phase 2 clinical study of gastrin analogue, TT-223.
Read More »New Gastrointestinal Treatment For Diabetes Using the EndoBarrier™ Liner
GI Dynamics announces data demonstrating immediate and sustained reduction in HbA1c in patients with type 2 diabetes using EndoBarrier™ Gastrointestinal Liner. Compelling clinical data highlighted at first World Congress on Interventional Therapies for Type 2 Diabetes show improved glycemic control and weight reduction in uncontrolled diabetics.
Read More »Newly Found Gene Variants Account for Kidney Disease
For the first time, researchers have identified variations in a single gene that are strongly associated with kidney diseases disproportionately affecting African-Americans. This work was conducted by researchers at the National Institutes of Health (NIH) and by NIH-funded investigators at the Johns Hopkins University.
Read More »Transforming Your Worst Habit
Many times you click on a publication about diabetes and you find out that most of the people involved have no real relation to diabetes. Everyone knows that Steve and I have been involved in patient care for years. We have taken it one step further with Andrew Young, coming …
Read More »Abdominal and lower-back resistance exercises: Crunches and waist worker
Dr. Sheri Colberg, Ph.D., FACSM, knows what parts of the body need the most help and the parts that most people want to fix this week she focuses on a major concern to all of us with Abdominal and lower-back resistance exercises: Crunches and the Waist Worker
Read More »Obesity Not A Red Flag For Diagnosing Diabetes
Obese people with diabetes are just as likely to go undiagnosed as their slimmer peers with the disease, Harvard Medical School researchers report.
Read More »Novel Short-Term Weight-Loss Approach Works Long-Term
A study by researchers from the Joslin Diabetes Center has shown for the first time that more than half of patients with type 2 diabetes who enrolled in a novel short-term weight management program were able to maintain the weight loss they achieved during the program on their own long-term. …
Read More »Januvia/Byetta Becoming First and Second-Line Therapy for Type 2 Diabetes
New research reports that Januvia is currently prescribed most often as a third- or later-line of therapy for the treatment of type 2 diabetes.
Read More »Genes Link Birth Weight, Diabetes In Adulthood
A large study of Swedish twins indicates that a common genetic cause underlies both low birth weight and the propensity to develop type 2 diabetes.
Read More »Low Vitamin D Levels Increases Risk of Type 2 Diabetes
New research shows that low vitamin D levels can increase the risk for developing diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.